All news

Mixed fortunes at Icon & Covance in Q3

Mixed fortunes at Icon & Covance in Q3

By Nick Taylor

The CRO results season is underway with Icon and Covance both posting mixed Q3 figures as the challenges facing pharma, and businesses in general, continue to impact on operations.

Follow us

Products

View more

Webinars